FDA rejects Athenex’s oral chemotherapy, asks for another clinical trial March 1, 2021 Auto Bot BioPharma, biopharma nl, breast cancer, chemotherapy, Clinical Trials, FDA, New York, News, Pharma 0 Athenex’s bid to offer an oral version of an intravenous chemotherapy has stalled after the FDA rejected the drug. Among the remedies proposed by the regulator is another Phase 3 study.